{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:45:10Z","timestamp":1791726310137,"version":"4.3.4"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,21]]},"DOI":"10.7759\/cureus.105579","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T08:43:54Z","timestamp":1774082634000},"source":"Crossref","is-referenced-by-count":1,"title":["Vulvovaginal Candidiasis Among Patients Attending the Gynecology Outpatient Department (GOPD) and STD Clinic With Special Reference to Their Antifungal Susceptibility and the Genetic Diversity of Non-albicans Candida in a Tertiary Care Hospital"],"prefix":"10.7759","author":[{"given":"Suranjana C","family":"Hazarika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshyasri","family":"Baishya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ridip","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishore","family":"Sarma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monjuri","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanto N","family":"Hazarika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/615958","article-title":"Non-albicans Candida infection: an emerging threat","volume":"2014","author":"Deorukhkar SC","year":"2014","unstructured":"Deorukhkar SC, Saini S, Mathew S. Non-albicans Candida infection: an emerging threat. Interdiscip Perspect Infect Dis. 2014, 2014:615958. 10.1155\/2014\/615958","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.18869\/acadpub.cmm.2.2.5","article-title":"Epidemiology and antifungal susceptibility of Candida species in a tertiary care hospital, Kolkata, India","volume":"2","author":"Bhattacharjee P","year":"2016","unstructured":"Bhattacharjee P. Epidemiology and antifungal susceptibility of Candida species in a tertiary care hospital, Kolkata, India. Curr Med Mycol. 2016, 2:20-7. 10.18869\/acadpub.cmm.2.2.5","journal-title":"Curr Med Mycol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1590\/S0100-72032004000100010","article-title":"Risk factors for vulvovaginal candidiasis: an exploratory study","volume":"26","author":"Rosa MI","year":"2004","unstructured":"Rosa MI, Rumel D. Risk factors for vulvovaginal candidiasis: an exploratory study. Rev Bras Ginecol Obstet. 2004, 26:65-70. 10.1590\/S0100-72032004000100010","journal-title":"Rev Bras Ginecol Obstet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2008.12.020","article-title":"Prevalence of Candida species and potential risk factors for vulvovaginal candidiasis in Aligarh, India","volume":"144","author":"Ahmad A","year":"2009","unstructured":"Ahmad A, Khan AU. Prevalence of Candida species and potential risk factors for vulvovaginal candidiasis in Aligarh, India. Eur J Obstet Gynecol Reprod Biol. 2009, 144:68-71. 10.1016\/j.ejogrb.2008.12.020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2017.04.105","article-title":"Identification of Candida species in vaginal flora using conventional and molecular methods","volume":"27","author":"Ameen F","year":"2017","unstructured":"Ameen F, Moslem M, Al Tami M, Al-Ajlan H, Al-Qahtani N. Identification of Candida species in vaginal flora using conventional and molecular methods. J Mycol Med. 2017, 27:364-8. 10.1016\/j.mycmed.2017.04.105","journal-title":"J Mycol Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-019-4793-z","article-title":"Candida vaginitis among symptomatic pregnant women attending antenatal clinics in Mwanza, Tanzania","volume":"12","author":"Mushi MF","year":"2019","unstructured":"Mushi MF, Mmole A, Mshana SE. Candida vaginitis among symptomatic pregnant women attending antenatal clinics in Mwanza, Tanzania. BMC Res Notes. 2019, 12:775. 10.1186\/s13104-019-4793-z","journal-title":"BMC Res Notes"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12281-021-00415-9","article-title":"Vulvovaginal candidiasis: epidemiology and risk factors, pathogenesis, resistance, and new therapeutic options","volume":"15","author":"de C\u00e1ssia Orlandi Sardi J","year":"2021","unstructured":"de C\u00e1ssia Orlandi Sardi J, Silva DR, Anibal PC, et al.. Vulvovaginal candidiasis: epidemiology and risk factors, pathogenesis, resistance, and new therapeutic options. Curr Fungal Infect Rep. 2021, 15:32-40. 10.1007\/s12281-021-00415-9","journal-title":"Curr Fungal Infect Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9378(98)80001-x","article-title":"Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations","volume":"178","author":"Sobel JD","year":"1998","unstructured":"Sobel JD, Faro S, Force RW, et al.. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol. 1998, 178:203-11. 10.1016\/s0002-9378(98)80001-x","journal-title":"Am J Obstet Gynecol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(07)60917-9","article-title":"Vulvovaginal candidosis","volume":"369","author":"Sobel JD","year":"2007","unstructured":"Sobel JD. Vulvovaginal candidosis. Lancet. 2007, 369:1961-71. 10.1016\/s0140-6736(07)60917-9","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2002.00432.x","article-title":"Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis","volume":"109","author":"Donders GG","year":"2002","unstructured":"Donders GG, Vereecken A, Bosmans E, Dekeersmaecker A, Salembier G, Spitz B. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG. 2002, 109:34-43. 10.1111\/j.1471-0528.2002.00432.x","journal-title":"BJOG"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12946","article-title":"Epidemiology and antifungal susceptibility patterns of Candida isolates from Greek women with vulvovaginal candidiasis","volume":"62","author":"Maraki S","year":"2019","unstructured":"Maraki S, Mavromanolaki VE, Stafylaki D, Nioti E, Hamilos G, Kasimati A. Epidemiology and antifungal susceptibility patterns of Candida isolates from Greek women with vulvovaginal candidiasis. Mycoses. 2019, 62:692-7. 10.1111\/myc.12946","journal-title":"Mycoses"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2174\/1573404815666191104142813","article-title":"Recurrent vulvovaginal candidiasis: the causative agents, clinical signs and susceptibility to fluconazole in Gonabad city, northeast Iran","volume":"16","author":"Minooeianhaghighi MH","year":"2020","unstructured":"Minooeianhaghighi MH, Sehatpour M, Zarrinfar H, Sen T. Recurrent vulvovaginal candidiasis: the causative agents, clinical signs and susceptibility to fluconazole in Gonabad city, northeast Iran. Curr Women's Health Rev. 2020, 16:46-51. 10.2174\/1573404815666191104142813","journal-title":"Curr Women's Health Rev"},{"key":"ref13","unstructured":"Laboratory manual for diagnosis of STI and RTI. (2014). https.\/\/naco.gov.in\/sites\/default\/files\/STI_Lab%20manual_09-01-2014.pdf."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-018-0607-z","article-title":"Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern","volume":"18","author":"Bitew A","year":"2018","unstructured":"Bitew A, Abebaw Y. Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern. BMC Womens Health. 2018, 18:94. 10.1186\/s12905-018-0607-z","journal-title":"BMC Womens Health"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/lam.13034","article-title":"Prevalence and antifungal susceptibility of Candida species among pregnant women attending a school maternity at Natal, Brazil","volume":"67","author":"Brand\u00e3o LD","year":"2018","unstructured":"Brand\u00e3o LD, Boniek D, Resende Stoianoff MA, da Mata FM, de Azevedo PR, Fernandes JV, Andrade VS. Prevalence and antifungal susceptibility of Candida species among pregnant women attending a school maternity at Natal, Brazil. Lett Appl Microbiol. 2018, 67:285-91. 10.1111\/lam.13034","journal-title":"Lett Appl Microbiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00076-09","article-title":"Candida infections of the genitourinary tract","volume":"23","author":"Achkar JM","year":"2010","unstructured":"Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clin Microbiol Rev. 2010, 23:253-73. 10.1128\/CMR.00076-09","journal-title":"Clin Microbiol Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3109\/1040841X.2015.1091805","article-title":"Vulvovaginal candidiasis: epidemiology, microbiology and risk factors","volume":"42","author":"Gon\u00e7alves B","year":"2016","unstructured":"Gon\u00e7alves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S. Vulvovaginal candidiasis: epidemiology, microbiology and risk factors. Crit Rev Microbiol. 2016, 42:905-27. 10.3109\/1040841X.2015.1091805","journal-title":"Crit Rev Microbiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-018-0261-x","article-title":"Genetic diversity and antifungal susceptibility of Candida parapsilosis sensu stricto isolated from bloodstream infections in Turkish patients","volume":"183","author":"Hilmio\u011flu-Polat S","year":"2018","unstructured":"Hilmio\u011flu-Polat S, Sharifynia S, \u00d6z Y, et al.. Genetic diversity and antifungal susceptibility of Candida parapsilosis sensu stricto isolated from bloodstream infections in Turkish patients. Mycopathologia. 2018, 183:701-8. 10.1007\/s11046-018-0261-x","journal-title":"Mycopathologia"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2020.0139","article-title":"Species distribution and antifungal susceptibility profiles of isolates from women with nonrecurrent and recurrent vulvovaginal candidiasis","volume":"27","author":"Rolo J","year":"2021","unstructured":"Rolo J, Faria-Gon\u00e7alves P, Barata T, et al.. Species distribution and antifungal susceptibility profiles of isolates from women with nonrecurrent and recurrent vulvovaginal candidiasis. Microb Drug Resist. 2021, 27:1087-95. 10.1089\/mdr.2020.0139","journal-title":"Microb Drug Resist"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.18502\/cmm.7.4.8405","article-title":"Characterization of Candida species isolated from vulvovaginal candidiasis by MALDI-TOF with in vitro antifungal susceptibility profiles","volume":"7","author":"Aslani N","year":"2021","unstructured":"Aslani N, Kokabi R, Moradi F, Abbasi K, Vaseghi N, Afsarian MH. Characterization of Candida species isolated from vulvovaginal candidiasis by MALDI-TOF with in vitro antifungal susceptibility profiles. Curr Med Mycol. 2021, 7:6-11. 10.18502\/cmm.7.4.8405","journal-title":"Curr Med Mycol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.7860\/NJLM\/2015\/13492:2057","article-title":"Evaluation of five phenotypic tests in the identification of candida species","volume":"4","author":"Giri S","year":"2015","unstructured":"Giri S, Kindo AJ. Evaluation of five phenotypic tests in the identification of candida species. Nat J Lab Med. 2015, 4:13-8. 10.7860\/NJLM\/2015\/13492:2057","journal-title":"Nat J Lab Med"},{"key":"ref22","article-title":"M44: Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts","author":"Procop GW","year":"2018","unstructured":"Procop GW, Alexander BD, Dufresne PJ, et al.. M44: Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania; 2018."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00937-12","article-title":"Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012","volume":"50","author":"Pfaller MA","year":"2012","unstructured":"Pfaller MA, Diekema DJ. Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012. J Clin Microbiol. 2012, 50:2846-56. 10.1128\/JCM.00937-12","journal-title":"J Clin Microbiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ1194","article-title":"Executive summary: clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas PG","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, et al.. Executive summary: clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016, 62:409-17. 10.1093\/cid\/civ1194","journal-title":"Clin Infect Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101510","article-title":"Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008","volume":"9","author":"Pfaller MA","year":"2014","unstructured":"Pfaller MA, Andes DR, Diekema DJ, et al.. Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008. PLoS One. 2014, 9:e101510. 10.1371\/journal.pone.0101510","journal-title":"PLoS One"},{"key":"ref26","unstructured":"Wizard\u00ae Genomic DNA Purification Kit. instructions for use of products A1120, A1123, A1125 and A1620. (2023). https:\/\/ita.promega.com\/-\/media\/files\/resources\/protocols\/technical-manuals\/0\/wizard-genomic-dna-purification-kit-pro...."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.11.4042-4051.2001","article-title":"Polymorphic internal transcribed spacer region 1 DNA sequences identify medically important yeasts","volume":"39","author":"Chen YC","year":"2001","unstructured":"Chen YC, Eisner JD, Kattar MM, et al.. Polymorphic internal transcribed spacer region 1 DNA sequences identify medically important yeasts. J Clin Microbiol. 2001, 39:4042-51. 10.1128\/JCM.39.11.4042-4051.2001","journal-title":"J Clin Microbiol"},{"key":"ref28","article-title":"Bioedit: a user-friendly biological sequence alignment editor and analysis program for Windows 95\/98\/NT","volume":"41","author":"Hall TA","year":"1999","unstructured":"Hall TA. Bioedit: a user-friendly biological sequence alignment editor and analysis program for Windows 95\/98\/NT. Nucleic Acids Symp Ser. 1999, 41:95-8.","journal-title":"Nucleic Acids Symp Ser"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msy096","article-title":"MEGA X: molecular evolutionary genetics analysis across computing platforms","volume":"35","author":"Kumar S","year":"2018","unstructured":"Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol. 2018, 35:1547-9. 10.1093\/molbev\/msy096","journal-title":"Mol Biol Evol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/jof6010027","article-title":"Vulvovaginal candidiasis: a current understanding and burning questions","volume":"6","author":"Willems HM","year":"2020","unstructured":"Willems HM, Ahmed SS, Liu J, Xu Z, Peters BM. Vulvovaginal candidiasis: a current understanding and burning questions. J Fungi (Basel). 2020, 6:27. 10.3390\/jof6010027","journal-title":"J Fungi (Basel)"},{"key":"ref31","article-title":"Clinical importance of detection of bacterial vaginosis, trichomonas vaginalis, candida albicans and actinomyces in Papanicolaou smears","volume":"39","author":"G\u00fcd\u00fcc\u00fc N","year":"2012","unstructured":"G\u00fcd\u00fcc\u00fc N, G\u00f6nen\u00e7 G, I\u015f\u00e7i H, Yi\u011fiter AB, Ba\u015fs\u00fcll\u00fc N, D\u00fcnder I. Clinical importance of detection of bacterial vaginosis, trichomonas vaginalis, candida albicans and actinomyces in Papanicolaou smears. Clin Exp Obstet Gynecol. 2012, 39:333-6.","journal-title":"Clin Exp Obstet Gynecol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.18502\/cmm.7.3.7801","article-title":"High incidence of azole resistance among Candida albicans and C. glabrata isolates in Northeastern Iran","volume":"7","author":"Zarrinfar H","year":"2021","unstructured":"Zarrinfar H, Kord Z, Fata A. High incidence of azole resistance among Candida albicans and C. glabrata isolates in Northeastern Iran. Curr Med Mycol. 2021, 7:18-21. 10.18502\/cmm.7.3.7801","journal-title":"Curr Med Mycol"},{"key":"ref33","article-title":"Candida infections: clinical features, diagnosis and treatment","volume":"2","author":"Bouopda Tamo SP","year":"2020","unstructured":"Bouopda Tamo SP. Candida infections: clinical features, diagnosis and treatment. Infect Dis Clin Microbiol. 2020, 2:91-102.","journal-title":"Infect Dis Clin Microbiol"},{"key":"ref34","article-title":"Frequency of variety of Candida species in women with Candida vaginitis referred to clinical centers of Mashhad, Iran","volume":"18","author":"Khorsand I","year":"2015","unstructured":"Khorsand I, Nehzag MG, Zarrinfar H, Fata A, Naseri A, Badiee P, Najafzadeh MJ. Frequency of variety of Candida species in women with Candida vaginitis referred to clinical centers of Mashhad, Iran. Iran J Obstet Gynecol Infertil. 2015, 18:15-22.","journal-title":"Iran J Obstet Gynecol Infertil"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.22038\/IJOGI.2017.8982","article-title":"Molecular identification of Candida species isolated from patients with vulvovaginitis for the first time in Mashhad","volume":"20","author":"Kord Z","year":"2017","unstructured":"Kord Z, Fata A, Zarrinfar H. Molecular identification of Candida species isolated from patients with vulvovaginitis for the first time in Mashhad. Iran J Obstet Gynecol Infertil. 2017, 20:50-7. 10.22038\/IJOGI.2017.8982","journal-title":"Iran J Obstet Gynecol Infertil"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.4103\/0377-4929.118703","article-title":"Emergence of non-albicans Candida among candidal vulvovaginitis cases and study of their potential virulence factors, from a tertiary care center, North India","volume":"56","author":"Kumari V","year":"2013","unstructured":"Kumari V, Banerjee T, Kumar P, Pandey S, Tilak R. Emergence of non-albicans Candida among candidal vulvovaginitis cases and study of their potential virulence factors, from a tertiary care center, North India. Indian J Pathol Microbiol. 2013, 56:144-7. 10.4103\/0377-4929.118703","journal-title":"Indian J Pathol Microbiol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2018.02.028","article-title":"Candida albicans - biology, molecular characterization, pathogenicity, and advances in diagnosis and control - an update","volume":"117","author":"Dadar M","year":"2018","unstructured":"Dadar M, Tiwari R, Karthik K, Chakraborty S, Shahali Y, Dhama K. Candida albicans - biology, molecular characterization, pathogenicity, and advances in diagnosis and control - an update. Microb Pathog. 2018, 117:128-38. 10.1016\/j.micpath.2018.02.028","journal-title":"Microb Pathog"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.4103\/jacm.jacm_24_22","article-title":"Vulvovaginal candidiasis: clinical profile, species distribution and antifungal susceptibility pattern","volume":"24","author":"Mariyah S","year":"2022","unstructured":"Mariyah S, Iyer RN, Jangam RR, Kesireddy S. Vulvovaginal candidiasis: clinical profile, species distribution and antifungal susceptibility pattern. J Acad Clin Microbiol. 2022, 24:71-5. 10.4103\/jacm.jacm_24_22","journal-title":"J Acad Clin Microbiol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2017\/23578.9475","article-title":"Fungal profile of vulvovaginal candidiasis in a tertiary care hospital","volume":"11","author":"Kalaiarasan K","year":"2017","unstructured":"Kalaiarasan K, Singh R, Chaturvedula L. Fungal profile of vulvovaginal candidiasis in a tertiary care hospital. J Clin Diagn Res. 2017, 11:DC06-9. 10.7860\/JCDR\/2017\/23578.9475","journal-title":"J Clin Diagn Res"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.4103\/2141-9248.160185","article-title":"Vulvovaginal candidiasis in Aminu Kano Teaching Hospital, North-West Nigeria: hospital-based epidemiological study","volume":"5","author":"Ugwa EA","year":"2015","unstructured":"Ugwa EA. Vulvovaginal candidiasis in Aminu Kano Teaching Hospital, North-West Nigeria: hospital-based epidemiological study. Ann Med Health Sci Res. 2015, 5:274-8. 10.4103\/2141-9248.160185","journal-title":"Ann Med Health Sci Res"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.18502\/cmm.4.1.27","article-title":"Prevalence of vulvovaginal candidiasis in gynecological practices in Germany: a retrospective study of 954,186 patients","volume":"4","author":"Jacob L","year":"2018","unstructured":"Jacob L, John M, Kalder M, Kostev K. Prevalence of vulvovaginal candidiasis in gynecological practices in Germany: a retrospective study of 954,186 patients. Curr Med Mycol. 2018, 4:6-11. 10.18502\/cmm.4.1.27","journal-title":"Curr Med Mycol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202505.1748.v1","article-title":"Epidemiology and antifungal resistance rates in vulvovaginal candidosis: results from a 5-year Greek survey, 2020 to 2024 [PREPRINT]","author":"Tsiakalos A","year":"2025","unstructured":"Tsiakalos A, Papageorgiou D, Vogiatzi C, et al.. Epidemiology and antifungal resistance rates in vulvovaginal candidosis: results from a 5-year Greek survey, 2020 to 2024 [PREPRINT]. Eur J Obstet Gynecol Reprod Biol. 2025, 10.20944\/preprints202505.1748.v1","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1097\/IM9.0000000000000095","article-title":"An epidemiologic analysis of vulvovaginal candidiasis and antifungal susceptibilities","volume":"4","author":"H\u00f6s\u00fcko\u011flu FG","year":"2022","unstructured":"H\u00f6s\u00fcko\u011flu FG, Ek\u015fi F, Erinmez M, U\u011fur MG. An epidemiologic analysis of vulvovaginal candidiasis and antifungal susceptibilities. Infect Microbes Dis. 2022, 4:131-6. 10.1097\/IM9.0000000000000095","journal-title":"Infect Microbes Dis"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.5812\/jjm.8(4)2015.15992","article-title":"Isolation of different species of Candida in patients with vulvovaginal candidiasis from Sari, Iran","volume":"8","author":"Hedayati MT","year":"2015","unstructured":"Hedayati MT, Taheri Z, Galinimoghadam T, Aghili SR, Yazdani Cherati J, Mosayebi E. Isolation of different species of Candida in patients with vulvovaginal candidiasis from Sari, Iran. Jundishapur J Microbiol. 2015, 8:e15992. 10.5812\/jjm.8(4)2015.15992","journal-title":"Jundishapur J Microbiol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-17668-x","article-title":"Recurrent vulvovaginal candidiasis: assessing the relationship between feminine\/vaginal washes and other factors among Ghanaian women","volume":"24","author":"Otoo-Annan E","year":"2024","unstructured":"Otoo-Annan E, Senoo-Dogbey VE. Recurrent vulvovaginal candidiasis: assessing the relationship between feminine\/vaginal washes and other factors among Ghanaian women. BMC Public Health. 2024, 24:100. 10.1186\/s12889-024-17668-x","journal-title":"BMC Public Health"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-022-01741-x","article-title":"Survey of incidence, lifetime prevalence, and treatment of self-reported vulvovaginal candidiasis, United States, 2020","volume":"22","author":"Benedict K","year":"2022","unstructured":"Benedict K, Singleton AL, Jackson BR, Molinari NA. Survey of incidence, lifetime prevalence, and treatment of self-reported vulvovaginal candidiasis, United States, 2020. BMC Womens Health. 2022, 22:147. 10.1186\/s12905-022-01741-x","journal-title":"BMC Womens Health"},{"key":"ref47","doi-asserted-by":"crossref","DOI":"10.4236\/ojmm.2020.103010","article-title":"Determining the prevalence of bacterial vaginosis & vulvovaginal candidiasis among married and unmarried women & evaluating the association socio-demographic risk factors & symptoms-related variables in women attending gynecology clinic in Hargeisa Group Hospital, Hargeisa City, Somaliland","volume":"10","author":"Al-Mamari A","year":"2020","unstructured":"Al-Mamari A. Determining the prevalence of bacterial vaginosis & vulvovaginal candidiasis among married and unmarried women & evaluating the association socio-demographic risk factors & symptoms-related variables in women attending gynecology clinic in Hargeisa Group Hospital, Hargeisa City, Somaliland. Open J Med Microbiol. 2020, 10:114-28.","journal-title":"Open J Med Microbiol"},{"key":"ref48","article-title":"A study on vulvovaginal candidiasis among non-pregnant women","volume":"4","author":"Kavitha Y","year":"2018","unstructured":"Kavitha Y, Mohan S, Anandi V, Babu H. A study on vulvovaginal candidiasis among non-pregnant women. Trop J Pathol Microbiol. 2018, 4:396-400.","journal-title":"Trop J Pathol Microbiol"},{"key":"ref49","article-title":"Vulvovaginal candidiasis among pregnant women attending a tertiary care centre and their antifungal susceptibility and biofilm formation","volume":"6","author":"Maheshwari P","year":"2025","unstructured":"Maheshwari P, Mundra P, Purohit M, Mahor A, Patil R. Vulvovaginal candidiasis among pregnant women attending a tertiary care centre and their antifungal susceptibility and biofilm formation. Int J Med Pharm Res. 2025, 6:149-58.","journal-title":"Int J Med Pharm Res"},{"key":"ref50","doi-asserted-by":"crossref","DOI":"10.17511\/ijmrr.2015.i1.12","article-title":"Vulvovaginal candidiasis and its antifungal susceptibility pattern: single center experience","volume":"3","author":"Rati R","year":"2015","unstructured":"Rati R, Patel J, Rishi S. Vulvovaginal candidiasis and its antifungal susceptibility pattern: single center experience. Int J Med Res Rev. 2015, 3:72-8.","journal-title":"Int J Med Res Rev"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2020.101049","article-title":"Epidemiology, risk factors and antimicrobial profile of vulvovaginal candidiasis (VVC): a study among women in the central region of Saudi Arabia","volume":"31","author":"Venugopal D","year":"2021","unstructured":"Venugopal D, Husain K, Mustafa SA, Sabeen S. Epidemiology, risk factors and antimicrobial profile of vulvovaginal candidiasis (VVC): a study among women in the central region of Saudi Arabia. J Mycol Med. 2021, 31:101049. 10.1016\/j.mycmed.2020.101049","journal-title":"J Mycol Med"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-04699-3","article-title":"Vulvovaginal candidiasis in rural pregnant populations from Uttar Pradesh, India: species shift, biofilm formation, and resistance trends","volume":"399","author":"Moursi SA","year":"2026","unstructured":"Moursi SA, Saxena R, Haider F, Khan MS, Saleem M, Ahmad I, Ahmad N. Vulvovaginal candidiasis in rural pregnant populations from Uttar Pradesh, India: species shift, biofilm formation, and resistance trends. Naunyn Schmiedebergs Arch Pharmacol. 2026, 399:3785-97. 10.1007\/s00210-025-04699-3","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-024-06844-x","article-title":"Vaginal candidiasis prevalence, associated factors, and antifungal susceptibility patterns among pregnant women attending antenatal care at bule hora university teaching hospital, Southern Ethiopia","volume":"24","author":"Hussen I","year":"2024","unstructured":"Hussen I, Aliyo A, Abbai MK, Dedecha W. Vaginal candidiasis prevalence, associated factors, and antifungal susceptibility patterns among pregnant women attending antenatal care at bule hora university teaching hospital, Southern Ethiopia. BMC Pregnancy Childbirth. 2024, 24:619. 10.1186\/s12884-024-06844-x","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1038\/s41435-019-0071-2","article-title":"Studying fungal pathogens of humans and fungal infections: fungal diversity and diversity of approaches","volume":"20","author":"Janbon G","year":"2019","unstructured":"Janbon G, Quintin J, Lanternier F, d'Enfert C. Studying fungal pathogens of humans and fungal infections: fungal diversity and diversity of approaches. Genes Immun. 2019, 20:403-14. 10.1038\/s41435-019-0071-2","journal-title":"Genes Immun"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0756.2008.00817.x","article-title":"Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006","volume":"34","author":"Fan SR","year":"2008","unstructured":"Fan SR, Liu XP, Li JW. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006. J Obstet Gynaecol Res. 2008, 34:561-6. 10.1111\/j.1447-0756.2008.00817.x","journal-title":"J Obstet Gynaecol Res"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00787-25","article-title":"Antifungal susceptibility profiles of Candida and non-albicans species isolated from pregnant women: implications for emerging antimicrobial resistance in maternal health","volume":"13","author":"Aboagye G","year":"2025","unstructured":"Aboagye G, Waikhom S, Asiamah EA, et al.. Antifungal susceptibility profiles of Candida and non-albicans species isolated from pregnant women: implications for emerging antimicrobial resistance in maternal health. Microbiol Spectr. 2025, 13:e0078725. 10.1128\/spectrum.00787-25","journal-title":"Microbiol Spectr"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2014\/6614.4003","article-title":"Profile of yeasts isolated from urinary tracts of catheterized patients","volume":"8","author":"Mishra M","year":"2014","unstructured":"Mishra M, Agrawal S, Raut S, Kurhade AM, Powar RM. Profile of yeasts isolated from urinary tracts of catheterized patients. J Clin Diagn Res. 2014, 8:44-6. 10.7860\/JCDR\/2014\/6614.4003","journal-title":"J Clin Diagn Res"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.58395\/2enj2697","article-title":"Species distribution and antifungal susceptibility of vaginal Candida isolates","volume":"52","author":"Hitkova H","year":"2024","unstructured":"Hitkova H, Georgieva D. Species distribution and antifungal susceptibility of vaginal Candida isolates. Probl Infect Parasit Dis. 2024, 52:13-7. 10.58395\/2enj2697","journal-title":"Probl Infect Parasit Dis"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv445","article-title":"Drug resistance mechanisms and their regulation in non-albicans Candida species","volume":"71","author":"Ko\u0142aczkowska A","year":"2016","unstructured":"Ko\u0142aczkowska A, Ko\u0142aczkowski M. Drug resistance mechanisms and their regulation in non-albicans Candida species. J Antimicrob Chemother. 2016, 71:1438-50. 10.1093\/jac\/dkv445","journal-title":"J Antimicrob Chemother"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.02173","article-title":"Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species","volume":"7","author":"Whaley SG","year":"2016","unstructured":"Whaley SG, Berkow EL, Rybak JM, Nishimoto AT, Barker KS, Rogers PD. Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species. Front Microbiol. 2016, 7:2173. 10.3389\/fmicb.2016.02173","journal-title":"Front Microbiol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp228","article-title":"Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model","volume":"64","author":"Gonz\u00e1lez GM","year":"2009","unstructured":"Gonz\u00e1lez GM, Portillo OJ, Uscanga GI, Andrade SE, Robledo M, Rodr\u00edguez C, Elizondo M. Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model. J Antimicrob Chemother. 2009, 64:571-3. 10.1093\/jac\/dkp228","journal-title":"J Antimicrob Chemother"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.21276\/ijmrp.2019.5.5.054","article-title":"Therapeutic efficacy of voriconazole in fluconazole resistant vaginal candidiasis","volume":"5","author":"Zeba D","year":"2019","unstructured":"Zeba D, Biswas R, Ali MS. Therapeutic efficacy of voriconazole in fluconazole resistant vaginal candidiasis. Int J Med Res Prof. 2019, 5:242-45. 10.21276\/ijmrp.2019.5.5.054","journal-title":"Int J Med Res Prof"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-09215-4","article-title":"Symptomatic vulvovaginal candidiasis and antifungal resistance in HIV-1 positive women at Mbarara city health centre IV","volume":"15","author":"Mbatudde N","year":"2025","unstructured":"Mbatudde N, Nalumaga PP, Bazira J, Kabanda T. Symptomatic vulvovaginal candidiasis and antifungal resistance in HIV-1 positive women at Mbarara city health centre IV. Sci Rep. 2025, 15:24123. 10.1038\/s41598-025-09215-4","journal-title":"Sci Rep"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-022-00687-w","article-title":"In vitro antifungal activity of azoles and other antifungal agents against pathogenic yeasts from vulvovaginal candidiasis in China","volume":"188","author":"Kan S","year":"2023","unstructured":"Kan S, Song N, Pang Q, et al.. In vitro antifungal activity of azoles and other antifungal agents against pathogenic yeasts from vulvovaginal candidiasis in China. Mycopathologia. 2023, 188:99-109. 10.1007\/s11046-022-00687-w","journal-title":"Mycopathologia"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-023-02583-9","article-title":"Lipid-based amphotericin B gel treatment eradicates vulvovaginal candidiasis in patients who failed to azole therapy","volume":"315","author":"Sheikh S","year":"2023","unstructured":"Sheikh S, Ahmad A, Ali SM, et al.. Lipid-based amphotericin B gel treatment eradicates vulvovaginal candidiasis in patients who failed to azole therapy. Arch Dermatol Res. 2023, 315:1939-44. 10.1007\/s00403-023-02583-9","journal-title":"Arch Dermatol Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/458262-vulvovaginal-candidiasis-among-patients-attending-the-gynecology-outpatient-department-gopd-and-std-clinic-with-special-reference-to-their-antifungal-susceptibility-and-the-genetic-diversity-of-non-albicans-candida-in-a-tertiary-care-hospital","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T08:43:57Z","timestamp":1774082637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/458262-vulvovaginal-candidiasis-among-patients-attending-the-gynecology-outpatient-department-gopd-and-std-clinic-with-special-reference-to-their-antifungal-susceptibility-and-the-genetic-diversity-of-non-albicans-candida-in-a-tertiary-care-hospital"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,21]]},"references-count":65,"URL":"https:\/\/doi.org\/10.7759\/cureus.105579","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,21]]}}}